Jasmine Zeki

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group

Risa Niemas-Teshiba, Ryosuke Matsuno, Larry Wang et al. · Oncotarget · 2017 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +17

In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment

Burçin Yavuz, Jasmine Zeki, Jeannine M. Coburn et al. · Journal of Controlled Release · 2018 · 24 citations

Pharmacy, Bioengineering, Oncology +6

Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression

Jordan S. Taylor, Jasmine Zeki, Kimberly J. Ornell et al. · Journal of Pediatric Surgery · 2019 · 23 citations · Full text

Medicine, Molecular Biology, Oncology +16

Epigenetic Targeting of <i>TERT</i> -Associated Gene Expression Signature in Human Neuroblastoma with <i>TERT</i> Overexpression

Min Huang, Jasmine Zeki, Nathan Sumarsono et al. · Cancer Research · 2020 · 21 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations

Burçin Yavuz, Jasmine Zeki, Jordan S. Taylor et al. · Journal of Pharmaceutical Sciences · 2019 · 20 citations · Full text

Pharmacy, Oncology, Pharmaceutics +14